- Home
- NICE vs ICLR Comparison
NICE vs ICLR Comparison
Compare NICE & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NICE | ICLR |
|---|---|---|
| Founded | 1986 | 1990 |
| Country | Israel | Ireland |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.6B | 14.3B |
| IPO Year | 1996 | 1998 |
Fundamental Metrics
Financial Performance| Metric | NICE | ICLR |
|---|---|---|
| Price | $109.25 | $186.40 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 14 |
| Target Price | $165.00 | ★ $201.23 |
| AVG Volume (30 Days) | ★ 1.2M | 1.0M |
| Earning Date | 11-13-2025 | 10-22-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 35.79 | N/A |
| EPS | ★ 8.79 | 7.47 |
| Revenue | $2,880,503,000.00 | ★ $8,102,602,000.00 |
| Revenue This Year | $9.57 | N/A |
| Revenue Next Year | $8.07 | $0.76 |
| P/E Ratio | ★ $12.43 | $25.41 |
| Revenue Growth | ★ 9.24 | N/A |
| 52 Week Low | $99.00 | $125.10 |
| 52 Week High | $193.42 | $228.29 |
Technical Indicators
Market Signals| Indicator | NICE | ICLR |
|---|---|---|
| Relative Strength Index (RSI) | 42.89 | 59.73 |
| Support Level | $103.23 | $178.80 |
| Resistance Level | $110.30 | $188.99 |
| Average True Range (ATR) | 2.92 | 7.59 |
| MACD | 1.28 | 1.34 |
| Stochastic Oscillator | 85.20 | 83.07 |
Price Performance
Historical ComparisonAbout NICE NICE Ltd
NICE Ltd is an enterprise software company that serves the customer engagement and financial crime and compliance markets. Software is deployed primarily on the cloud, but also on premises. Within customer engagement, Nice's CXone is the leading CCaaS platform providing solutions such as call routing, interactive voice response, digital self-service, and workforce engagement management. Within financial crime and compliance, Nice offers risk and investigation management, fraud prevention, anti-money-laundering, and compliance solutions.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.